2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells

Salama A. Salama, Concepcion R. Diaz-Arrastia, Gokhan Kilic, Marwa W. Kamel

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To investigate the effects and the mechanism of action of 2-methoxyestradiol (2ME 2) on transforming growth factor (TGF) β3-induced profibrotic response in immortalized human uterine fibroid smooth muscle (huLM) cells. Design: Laboratory study. Setting: University research laboratory. Patients(s): Not applicable. Interventions(s): Not applicable. Main Outcome Measure(s): huLM cells were treated with TGF-β3 (5 ηg/mL) in the presence or absence of specific Smad3 inhibitor SIS3 (1 μmol/L), inhibitor of the PI3K/Akt (LY294002, 10 μmol/L), or 2ME 2 (0.5 μmol/L), and the expression of collagen (Col) type I(αI), Col III(αI), plasminogen activator inhibitor (PAI) 1, connective tissue growth factor (CTGF), and α-smooth muscle actin (α-SMA) were determined by real-time reverse-transcription polymerase chain reaction and immunoblotting. The effect of 2ME 2 on Smad-microtubule binding was evaluated by coimmunoprecipitation. Result(s): Our data revealed that TGF-β3-induced fibrogenic response in huLM is mediated by both Smad-dependent and Smad-independent PI3K/Akt/mTOR signaling pathways. 2ME 2 abrogates TGF-β3-induced expression of Col I(αI), Col III(αI), PAI-1, CTGF, and α-SMA. Molecularly, 2ME 2 ameliorates TGF-β3-induced Smad2/3 phosphorylation and nuclear translocation. In addition, 2ME 2 inhibits TGF-β3-induced activation of the PI3K/Akt/mTOR pathway. Conclusion(s): TGF-β3-induced profibrotic response in fibroid cells is mediated by Smad-dependent and Smad-independent PI3K/Akt/mTOR pathways. 2ME 2 inhibits TGF-β3 profibrotic effects in huLM cells by ameliorating both Smad-dependent and Smad-independent signaling pathways.

Original languageEnglish (US)
Pages (from-to)178-184
Number of pages7
JournalFertility and Sterility
Volume98
Issue number1
DOIs
StatePublished - Jul 2012

Fingerprint

Leiomyoma
Transforming Growth Factors
Phosphatidylinositol 3-Kinases
Connective Tissue Growth Factor
Collagen
Plasminogen Activator Inhibitor 1
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
2-methoxyestradiol
Collagen Type I
Immunoblotting
Microtubules
Reverse Transcription
Smooth Muscle Myocytes
Smooth Muscle
Actins
Phosphorylation
Outcome Assessment (Health Care)
Polymerase Chain Reaction
Research

Keywords

  • 2-methoxyestradiol
  • Transforming growth factor β signaling
  • uterine fibroids

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells. / Salama, Salama A.; Diaz-Arrastia, Concepcion R.; Kilic, Gokhan; Kamel, Marwa W.

In: Fertility and Sterility, Vol. 98, No. 1, 07.2012, p. 178-184.

Research output: Contribution to journalArticle

@article{adde01e82d0e4ca6b337967cdcaadcdd,
title = "2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells",
abstract = "Objective: To investigate the effects and the mechanism of action of 2-methoxyestradiol (2ME 2) on transforming growth factor (TGF) β3-induced profibrotic response in immortalized human uterine fibroid smooth muscle (huLM) cells. Design: Laboratory study. Setting: University research laboratory. Patients(s): Not applicable. Interventions(s): Not applicable. Main Outcome Measure(s): huLM cells were treated with TGF-β3 (5 ηg/mL) in the presence or absence of specific Smad3 inhibitor SIS3 (1 μmol/L), inhibitor of the PI3K/Akt (LY294002, 10 μmol/L), or 2ME 2 (0.5 μmol/L), and the expression of collagen (Col) type I(αI), Col III(αI), plasminogen activator inhibitor (PAI) 1, connective tissue growth factor (CTGF), and α-smooth muscle actin (α-SMA) were determined by real-time reverse-transcription polymerase chain reaction and immunoblotting. The effect of 2ME 2 on Smad-microtubule binding was evaluated by coimmunoprecipitation. Result(s): Our data revealed that TGF-β3-induced fibrogenic response in huLM is mediated by both Smad-dependent and Smad-independent PI3K/Akt/mTOR signaling pathways. 2ME 2 abrogates TGF-β3-induced expression of Col I(αI), Col III(αI), PAI-1, CTGF, and α-SMA. Molecularly, 2ME 2 ameliorates TGF-β3-induced Smad2/3 phosphorylation and nuclear translocation. In addition, 2ME 2 inhibits TGF-β3-induced activation of the PI3K/Akt/mTOR pathway. Conclusion(s): TGF-β3-induced profibrotic response in fibroid cells is mediated by Smad-dependent and Smad-independent PI3K/Akt/mTOR pathways. 2ME 2 inhibits TGF-β3 profibrotic effects in huLM cells by ameliorating both Smad-dependent and Smad-independent signaling pathways.",
keywords = "2-methoxyestradiol, Transforming growth factor β signaling, uterine fibroids",
author = "Salama, {Salama A.} and Diaz-Arrastia, {Concepcion R.} and Gokhan Kilic and Kamel, {Marwa W.}",
year = "2012",
month = "7",
doi = "10.1016/j.fertnstert.2012.04.002",
language = "English (US)",
volume = "98",
pages = "178--184",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - 2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells

AU - Salama, Salama A.

AU - Diaz-Arrastia, Concepcion R.

AU - Kilic, Gokhan

AU - Kamel, Marwa W.

PY - 2012/7

Y1 - 2012/7

N2 - Objective: To investigate the effects and the mechanism of action of 2-methoxyestradiol (2ME 2) on transforming growth factor (TGF) β3-induced profibrotic response in immortalized human uterine fibroid smooth muscle (huLM) cells. Design: Laboratory study. Setting: University research laboratory. Patients(s): Not applicable. Interventions(s): Not applicable. Main Outcome Measure(s): huLM cells were treated with TGF-β3 (5 ηg/mL) in the presence or absence of specific Smad3 inhibitor SIS3 (1 μmol/L), inhibitor of the PI3K/Akt (LY294002, 10 μmol/L), or 2ME 2 (0.5 μmol/L), and the expression of collagen (Col) type I(αI), Col III(αI), plasminogen activator inhibitor (PAI) 1, connective tissue growth factor (CTGF), and α-smooth muscle actin (α-SMA) were determined by real-time reverse-transcription polymerase chain reaction and immunoblotting. The effect of 2ME 2 on Smad-microtubule binding was evaluated by coimmunoprecipitation. Result(s): Our data revealed that TGF-β3-induced fibrogenic response in huLM is mediated by both Smad-dependent and Smad-independent PI3K/Akt/mTOR signaling pathways. 2ME 2 abrogates TGF-β3-induced expression of Col I(αI), Col III(αI), PAI-1, CTGF, and α-SMA. Molecularly, 2ME 2 ameliorates TGF-β3-induced Smad2/3 phosphorylation and nuclear translocation. In addition, 2ME 2 inhibits TGF-β3-induced activation of the PI3K/Akt/mTOR pathway. Conclusion(s): TGF-β3-induced profibrotic response in fibroid cells is mediated by Smad-dependent and Smad-independent PI3K/Akt/mTOR pathways. 2ME 2 inhibits TGF-β3 profibrotic effects in huLM cells by ameliorating both Smad-dependent and Smad-independent signaling pathways.

AB - Objective: To investigate the effects and the mechanism of action of 2-methoxyestradiol (2ME 2) on transforming growth factor (TGF) β3-induced profibrotic response in immortalized human uterine fibroid smooth muscle (huLM) cells. Design: Laboratory study. Setting: University research laboratory. Patients(s): Not applicable. Interventions(s): Not applicable. Main Outcome Measure(s): huLM cells were treated with TGF-β3 (5 ηg/mL) in the presence or absence of specific Smad3 inhibitor SIS3 (1 μmol/L), inhibitor of the PI3K/Akt (LY294002, 10 μmol/L), or 2ME 2 (0.5 μmol/L), and the expression of collagen (Col) type I(αI), Col III(αI), plasminogen activator inhibitor (PAI) 1, connective tissue growth factor (CTGF), and α-smooth muscle actin (α-SMA) were determined by real-time reverse-transcription polymerase chain reaction and immunoblotting. The effect of 2ME 2 on Smad-microtubule binding was evaluated by coimmunoprecipitation. Result(s): Our data revealed that TGF-β3-induced fibrogenic response in huLM is mediated by both Smad-dependent and Smad-independent PI3K/Akt/mTOR signaling pathways. 2ME 2 abrogates TGF-β3-induced expression of Col I(αI), Col III(αI), PAI-1, CTGF, and α-SMA. Molecularly, 2ME 2 ameliorates TGF-β3-induced Smad2/3 phosphorylation and nuclear translocation. In addition, 2ME 2 inhibits TGF-β3-induced activation of the PI3K/Akt/mTOR pathway. Conclusion(s): TGF-β3-induced profibrotic response in fibroid cells is mediated by Smad-dependent and Smad-independent PI3K/Akt/mTOR pathways. 2ME 2 inhibits TGF-β3 profibrotic effects in huLM cells by ameliorating both Smad-dependent and Smad-independent signaling pathways.

KW - 2-methoxyestradiol

KW - Transforming growth factor β signaling

KW - uterine fibroids

UR - http://www.scopus.com/inward/record.url?scp=84863004802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863004802&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2012.04.002

DO - 10.1016/j.fertnstert.2012.04.002

M3 - Article

VL - 98

SP - 178

EP - 184

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -